Home › NDC Lookup › Ingredients › Verapamil Hydrochloride › 70771-1601-07
Verapamil Hydrochloride 2.5 mg/mL Injection, Solution — NDC 70771-1601-07 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Verapamil Hydrochloride 2.5 mg/mL Injection, Solution — NDC 70771-1601-7 (Billing 70771-1601-07)

by Zydus Lifesciences Limited · 25 CARTON in 1 CARTON / 5 VIAL in 1 CARTON / 2 mL in 1 VIAL

This is a package of Verapamil Hydrochloride 2.5 mg/mL Injection, Solution from Zydus Lifesciences Limited, marketed since Oct 2020 and currently FDA-listed. It is this product's only package size.

NDC 70771-1601-07
🏷️ FDA NDC (as labeled) 70771-1601-7 billing pads the package segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Verapamil Hydrochloride (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class III · Jul 2, 2024 — Cross contamination with other products. (Zydus Pharmaceuticals (USA) Inc) · FDA recall D-0592-2024
Class III · Jul 2, 2024 — Cross contamination with other products. (Zydus Pharmaceuticals (USA) Inc) · FDA recall D-0593-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70771-1601-7
Product NDC 70771-1601
11-digit billing NDC 70771160107
RxCUI 898316, 1665057
UNII V3888OEY5R
Application # ANDA214215
SPL Set ID cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8
Established class (EPC) Calcium Channel Blocker
Mechanism of action Calcium Channel Antagonists; Cytochrome P450 3A Inhibitors; Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-10-22
Route INTRAVENOUS
Dosage form INJECTION, SOLUTION
Substance VERAPAMIL HYDROCHLORIDE
TE code (Orange Book) AP · RLD · RS
Quick answers
  • RxCUI (RxNorm): 898316
Why two NDCs? The FDA registers this code as 70771-1601-7 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1601-07. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Calcium Channel Blocker class.

Pharmacologic class Calcium Channel Blocker
Drug family (ATC) Phenylalkylamine derivatives, ACE inhibitors and calcium channel blockers
How it works Calcium Channel Antagonists, Cytochrome P450 3A4 Inhibitors, P-Glycoprotein Inhibitors, Cytochrome P450 3A Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Verapamil tablets treat angina, certain fast heart rhythms and high blood pressure. Extended-release forms are used for high blood pressure. The injectio...
  • Extended-release tablets are taken with food in the morning. The PM capsules are taken at bedtime. Swallow capsules whole, or sprinkle the entire contents on applesauce. Never crus...
  • How should I take my extended-release verapamil?
  • Constipation is the most common, along with headache, dizziness and ankle swelling. Tell your doctor if they bother you. Call right away for fainting, a very slow heartbeat, shortn...
📖 Read our full Verapamil guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
2
Nutrient depletion considerations

Verapamil may be associated with lower levels of 2 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Verapamil nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70771-1601-07 You're viewing this Main listing 25 CARTON in 1 CARTON / 5 VIAL in 1 CARTON / 2 mL in 1 VIAL 2020-10-22 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Verapamil Hydrochloride 2.5 mg/mL 00404-9966-02 Henry 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 00409-1144-02 Hospira, 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 00409-4011-01 Hospira, 5 ampules — AP FDA listed —
Verapamil hydrochloride 2.5 mg/mL 23155-0911-41 Heritage 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 25021-0312-02 Sagent 25 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 42571-0313-75 Micro 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 43066-0031-25 Baxter 25 vials — AP FDA listed —
Verapamil Hci 2.5 mg/mL 51662-1269-01 HF 2 ml — AP FDA listed —
Verapamil Hci 2.5 mg/mL 51662-1442-01 HF 2 ml — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51662-1549-01 HF 2 ml — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51662-1686-03 HF 25 pouches — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51754-0203-02 EXELA 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51754-0204-02 EXELA 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 55150-0342-01 Eugia 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 65145-0113-25 Caplin 25 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 65219-0384-02 FRESENIUS 25 vials — AP FDA listed —
Verapamil hydrochloride 2.5 mg/mL 68083-0447-25 Gland 25 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70069-0271-05 Somerset 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70069-0273-05 Somerset 5 ampules — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70121-1585-05 Amneal 25 vials — — FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70518-4453-00 REMEDYREPACK 25 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70710-1643-07 Zydus 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70710-1937-07 Zydus 5 vials — AP FDA listed —
verapamil hydrochloride 2.5 mg/mL 70756-0605-25 Lifestar 25 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mLthis 70771-1601-07 Zydus 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 71872-7048-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 71872-7183-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 5 mg/2mL 71872-7203-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 5 mg/2mL 71872-7210-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 71872-7243-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 71872-7291-01 Medical 1 vial — AP FDA listed —
verapamil hydrochloride 2.5 mg/mL 71872-7356-01 Medical 1 vial — AP FDA listed —
Verapamil Hydrochloride 5 mg/2mL 72485-0108-05 Armas 5 vials — AP FDA listed —
verapamil hydrochloride 2.5 mg/mL 84549-0605-25 ProPharma 2 ml — AP FDA listed —
Verapamil hydrochloride 2.5 mg/mL 68083-0448-05 Gland 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70771-1602-05 Zydus 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 55150-0343-01 Eugia 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70069-0272-05 Somerset 5 vials — AP FDA listed —
verapamil hydrochloride 2.5 mg/mL 70756-0606-05 Lifestar 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 00404-9967-04 Henry 1 vial — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 43066-0035-05 Baxter 5 vials — AP FDA listed —
Verapamil hydrochloride 2.5 mg/mL 23155-0912-41 Heritage 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 65145-0114-05 Caplin 5 vials — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70121-1586-03 Amneal 5 vials — — FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51662-1270-01 HF 1 syringe — — FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 00404-9968-04 Henry 1 syringe — — FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51662-1398-01 HF 4 ml — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 51662-1685-01 HF 4 ml — AP FDA listed —
Verapamil Hydrochloride 2.5 mg/mL 70710-1644-05 Zydus 5 vials — AP FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Oct 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA214215 (ANDA)
Labeler code70771
First marketedOct 2020
Product typeHuman Prescription Drug
Portfolio720 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel
📄 Package Label / Principal Display Panel 157 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771- 1601-1 Verapamil Hydrochloride Injection, USP 5 mg/2 mL (2.5 mg/mL) For Intravenous Use Only Protect from light. 2 mL Single-Dose Vial Rx only NDC 70771- 1601-5 Verapamil Hydrochloride Injection, USP 5 mg/2 mL (2.5 mg/mL) For Intravenous Use Only Protect from light. 5 X 2 mL Single-Dose Vials Rx only NDC 70771- 1601-7 Verapamil Hydrochloride Injection, USP 5 mg/2 mL (2.5 mg/mL) For Intravenous Use Only Protect from light.

25 X 2 mL Single-Dose Vials Rx only 2 mL vial carton of 5 vials carton of 25 vials

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771- 1602-1 Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL) For Intravenous Use Only Protect from light. 4 mL Single-Dose Vial Rx only NDC 70771- 1602-5 Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL) For Intravenous Use Only Protect from light. 5 X 4 mL Single-Dose Vials Rx only 4 mL vial carton of 5 vials

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70771-1600-00 · Zydus 70771-1602-05 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.